Leo Mortimer

Leo Mortimer is an accomplished scientist with extensive experience in biotherapeutics, peptide chemistry, and data review. Currently serving as Associate Scientist III at Inotiv since October 2022, Leo specializes in developing and validating ligand binding assays for pharmacokinetics and biomarkers, and has expertise in flow cytometry and antibody conjugation methods. Previously held positions include Associate Scientist at BioNTech SE and Sr Research Associate II at Kite Pharma, where Leo focused on peptide synthesis for cancer research. Other roles span across various organizations, demonstrating proficiency in ELISA method development, sales and marketing, and molecular genetics. Leo's educational background includes an MS in Biology from Duquesne University, an MBA in Marketing from the University of Pittsburgh, and a BA in Biology from Thiel College.